Nautilus Biotechnology Inc (NAUT) Gross Profit Margin starting from the third quarter 2026 to third quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Nautilus Biotechnology Inc   (NASDAQ: NAUT)


Nautilus Biotechnology Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



NAUT Gross Profit Margin (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Revenue Change -
Seq. Revenue Change 23.16 %
Revenue In Millions $0.23
Gross Profit Margin 89.74 %
Gross Profit Margin Total Ranking #
Gross Profit In Millions $0.21
Y / Y Gross Profit Change -
Seq. Gross Profit Change 20 %


Commenting Third Quarter 2026 Gross Profit Margin
Nautilus Biotechnology Inc has managed to improve its Revenue sequentially to $0.23 millions by 23.16 % faster than Gross Profit increase of 20 % to $0.21 millions, this led to contraction in Gross Profit Margin to 89.74 %, a new company low.


Observing third quarter 2026 results within Laboratory Analytical Instruments industry Nautilus Biotechnology Inc has achieved highest Gross Profit Margin. While overall Gross Profit Margin ranking remained unchanged compared to the previous quarter at no. .
Learn about Gross Margin
NAUT's Gross Profit Margin third quarter 2026 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall # 0

Gross Profit Margin Statistics
High Average Low
92.11 % 90.92 % 89.74 %
(Jun 30 2026)   (Sep 30 2026)




Other Gross Profit Margin Profitability Ratios
NAUT's Cumulative Gross Profit Margin
Laboratory Analytical Instruments Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
NAUT's Gross Profit Margin Profitability versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for NAUT's Competitors
Gross Profit Margin Profit Margin for Nautilus Biotechnology Inc 's Suppliers
Gross Profit Margin Profit Margin for NAUT's Customers

You may also want to know
NAUT's Annual Growth Rates NAUT's Profitability Ratios NAUT's Asset Turnover Ratio NAUT's Dividend Growth
NAUT's Roe NAUT's Valuation Ratios NAUT's Financial Strength Ratios NAUT's Gross Profit Growth
NAUT's Roa NAUT's Inventory Turnover Ratio NAUT's Growth Rates NAUT's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2026, within Laboratory Analytical Instruments Industry Gross Profit MarginSep 30 2026 MRQ Gross ProfitSep 30 2026 MRQ Revenue
Nautilus Biotechnology Inc   89.74 %$ 0.210  Millions$ 0.234  Millions
10x Genomics Inc   74.95 %$ 112.927  Millions$ 150.667  Millions
Illumina Inc   73.52 %$ 830.000  Millions$ 1,129.000  Millions
Alamar Biosciences Inc   61.54 %$ 20.644  Millions$ 33.545  Millions
Mettler toledo International Inc   59.79 %$ 654.224  Millions$ 1,094.294  Millions
Cytek Biosciences Inc   58.63 %$ 31.206  Millions$ 53.229  Millions
Standard Biotools Inc   55.86 %$ 10.828  Millions$ 19.385  Millions
Bio rad Laboratories Inc   50.06 %$ 328.600  Millions$ 656.400  Millions
Bruker Corporation  49.12 %$ 429.300  Millions$ 874.000  Millions
Quanterix Corporation  38.60 %$ 13.500  Millions$ 34.974  Millions
Pacific Biosciences Of California Inc   33.21 %$ 13.470  Millions$ 40.564  Millions
Avantor Inc   31.49 %$ 534.800  Millions$ 1,698.300  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.